Navigation Links
Greenberg Traurig Shareholder Jennifer A. Camacho Selected to Receive Mass High Tech's 2011 All-Stars Award
Date:9/9/2011

BOSTON, Sept. 9, 2011 /PRNewswire/ -- Mass High Tech has selected Greenberg Traurig shareholder Jennifer A. Camacho to be a recipient of its 2011 All-Stars Award, one that recognizes 15 driven and influential leaders of New England's innovation economy.  

Camacho will be recognized for her wide range of experience in and contribution to the life sciences sector.  As a patent attorney, she represents pharmaceutical and biotechnology clients. Camacho brings a real-world perspective to client representation from her tenure as chief patent counsel, vice president of intellectual property and general counsel at a venture-backed start-up company in the emerging field of synthetic biology and DNA synthesis.  She is a founding team member for the International Consortium for Polynucleotide Synthesis, Inc., and currently serves on the board of directors for the Center for Policy on Emerging Technologies in Washington, D.C.  In addition,  Camacho serves as a judge and mentor for the MassChallenge, Inc. annual startup competition and accelerator program.

"The 2011 All-Stars have a proven record in leading not only their own companies but in helping their industry thrive and in guiding entrepreneurs who are building the successful tech companies of tomorrow," said Mass High Tech publisher Doug Banks.  "The companies and industries that they have helped to build are the basis of the economic engine that provides jobs and spawns innovation throughout New England and the United States."

Honorees will be profiled in a special report on MassHighTech.com and recognized at an evening awards celebration and networking reception on Wednesday, November 16th, at the House of Blues in Boston.

About Greenberg Traurig, LLP

Greenberg Traurig, LLP is an international, full-service law firm with approximately 1,800 attorneys serving clients from more than 30 offices in the United States, Europe and Asia. In the U.S., the firm has more offices than any other among the Top 10 on The National Law Journal's 2011 NLJ 250. In the U.K., the firm operates as Greenberg Traurig Maher LLP. Greenberg Traurig has a strategic alliance with the independent law firm, Studio Santa Maria in Milan and Rome. The firm was Chambers and Partners' USA Law Firm of the Year in 2007 and among the Top 3 in the International Law Firm of the Year at the 2009 The Lawyer Awards. For additional information, please visit www.gtlaw.com.


'/>"/>
SOURCE Greenberg Traurig, LLP
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
2. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
3. Mymetics Corporation Important Shareholders Information Conference Call
4. Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
5. Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
6. Chromos announces shareholder approval of Arrangement
7. Sangui Bio Tech International Inc. Shareholders Meeting Delayed to Include FY 2008 Report
8. ARIUS sale approved by shareholders
9. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
10. China-Biotics, Inc. Announces Results of 2008 Annual General Meeting of Shareholders
11. Insmed to Seek Shareholder Approval for Reverse Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... 22, 2017 , ... Researchers face a fundamental challenge as ... full-size tissues, bones, even whole organs to implant in people to treat disease ... into the developing tissue. , Current bioengineering techniques, including 3-D printing, can’t ...
(Date:3/22/2017)... CAMBRIDGE, Mass. , March 22, 2017 ... announced that it has eclipsed the 130 million covered ... Cross Blue Shield of Texas . ... stages, the Company continues to enjoy strong payor acceptance ... of its clinical programs and genetic counseling, its industry-leading ...
(Date:3/22/2017)... 22, 2017 The global chronic ... research report by Transparency Market Research (TMR). The top ... and AbbVie Inc., accounted for a share of only ... in this market are focusing aggressively on mergers, acquisitions, ... is likely to lead to market consolidation in the ...
(Date:3/22/2017)... Mass. , March 22, 2017   Boston ... next-generation cancer therapeutics designed to target cancer stemness pathways, ... Patricia S. Andrews as Chief Executive Officer, effective ... succeed Chiang J. Li , M.D., FACP, who ... ten years ago. Under his leadership, Boston Biomedical has ...
Breaking Biology Technology:
(Date:3/6/2017)... SAN MATEO, Calif. , March 6, 2017 ... predictive marketing and sales technology, today announced Predictive ... (AI) solution for infusing actionable sales intelligence into ... customers to automatically enable their sales organizations with ... contextual messages that allow for intelligent engagement. Predictive ...
(Date:3/2/2017)... -- Australian stem cell and regenerative medicine company, ... agreement with the Monash Lung Biology Network, a consortia ... Department of Pharmacology at Monash University, Melbourne ... support the use of Cymerus™ mesenchymal stem cells (MSCs) ... is a chronic, long term lung condition recognised by ...
(Date:2/28/2017)... 27. Februar 2017  EyeLock LLC, ein marktführendes Unternehmen ... erstklassige biometrische Lösung zur Iris-Erkennung auf der ... LTE auf dem Mobile World Congress 2017 ... in Halle 3, Stand 3E10, vorstellen. ... Qualcomm Haven™ – eine Kombination aus Hardware, ...
Breaking Biology News(10 mins):